Understanding how antibody treatments work in different biological environments
Quantitative Systems Pharmacology of Antibody Therapeutics across Diverse Biological Contexts
This study is looking at how antibody treatments work differently in various parts of the body and how our immune system responds, with the goal of helping patients get more effective treatments tailored to their specific needs.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-11015786 on NIH RePORTER |
What this research studies
This research investigates the pharmacology of antibody-based therapies, focusing on how their effectiveness can vary depending on the biological context in which they are used. By developing advanced models and experimental tools, the research aims to analyze factors such as tissue-specific drug behavior and immune responses. Patients may benefit from a better understanding of how these therapies can be optimized for individual conditions, potentially leading to more effective treatments. The study seeks to address the high failure rates in antibody drug development by providing insights into the complex interactions that influence treatment outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals receiving or considering antibody-based treatments for various conditions.
Not a fit: Patients who are not receiving antibody therapies or those with conditions not addressed by antibody treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized antibody therapies for patients.
How similar studies have performed: Previous research has shown promise in understanding antibody pharmacology, but this approach aims to refine and expand on those findings in a novel way.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Cao, Yanguang — Univ of North Carolina Chapel Hill
- Study coordinator: Cao, Yanguang
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.